CME - CME Group Inc. Stock Analysis | Stock Taper
Logo
CME Group Inc.

CME

CME Group Inc. NASDAQ
$319.50 0.96% (+3.05)

Market Cap $114.86 B
52w High $322.57
52w Low $248.53
Dividend Yield 4.06%
Frequency Irregular
P/E 28.65
Volume 2.81M
Outstanding Shares 359.51M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $1.65B $388M $1.17B 70.84% $3.25 $1.59B
Q3-2025 $1.54B $327.4M $908M 59.05% $2.49 $1.3B
Q2-2025 $1.69B $341.1M $1.01B 59.82% $2.81 $1.46B
Q1-2025 $1.64B $327.6M $956.2M 58.22% $2.63 $1.37B
Q4-2024 $1.53B $357.4M $874.6M 57.34% $2.4 $1.22B

What's going well?

Profits and earnings per share jumped sharply, helped by higher revenue and a big boost from other income. Gross margins remain very high, showing the business is efficient and profitable.

What's concerning?

Operating expenses are growing faster than revenue, which could pressure profits if it continues. A large portion of earnings comes from other income, not just the core business.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $4.55B $198.42B $169.7B $28.73B
Q3-2025 $2.57B $187.14B $158.95B $28.19B
Q2-2025 $2.1B $179.91B $152.17B $27.74B
Q1-2025 $1.52B $157.83B $130.8B $27.03B
Q4-2024 $3.01B $137.45B $110.96B $26.49B

What's financially strong about this company?

CME has more cash than debt, and its total debt is very low compared to its size. Shareholder equity is healthy and growing, and most assets are tangible or liquid.

What are the financial risks or weaknesses?

Current liabilities are extremely high, and current assets are reported as zero, which could signal a liquidity crunch if not a reporting issue. There is also a large chunk of goodwill and intangibles that could be written down.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $1.18B $3.16B $1.51B $-19.21B $0 $3.16B
Q3-2025 $908M $968.1M $-19.1M $6.4B $465.5M $949.7M
Q2-2025 $1.03B $1.06B $-18M $21B $576.2M $1.04B
Q1-2025 $956.2M $1.12B $-16M $19.21B $20.31B $1.1B
Q4-2024 $874.6M $1.02B $-25.3M $-984.1M $8.5M $991.7M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
clearing and transaction fees
clearing and transaction fees
$1.34Bn $1.39Bn $1.23Bn $1.33Bn
MarketData
MarketData
$190.00M $200.00M $200.00M $210.00M
OtherRevenue
OtherRevenue
$110.00M $110.00M $110.00M $110.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at CME Group Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

CME combines a rare set of strengths: steadily growing revenue, exceptionally high and improving profit margins, strong and rising free cash flow, and a conservative balance sheet with low net leverage and growing cash. Its market position is entrenched through powerful network effects, trusted central clearing, and a broad suite of benchmark products across multiple asset classes. Technological capabilities—anchored by Globex, the Google Cloud migration, and data and analytics offerings—further enhance its role as critical financial infrastructure. This financial and competitive profile provides significant resilience and strategic flexibility.

! Risks

Key risks cluster around market structure, regulation, and execution. Trading and clearing volumes are sensitive to volatility, interest‑rate cycles, and macro conditions, which can slow growth in quieter periods. Regulatory changes could reshape economics in key products or invite more competition. The large and complex technology initiatives underway, particularly the cloud migration and new clearing services, carry operational and execution risk. Balance sheet anomalies in the latest year, including the disappearance of reported current items and retained earnings, point to changes that need to be understood in detail. Finally, the lack of explicit R&D disclosure makes it harder to assess long‑term investment levels in technology relative to emerging competitors, especially in areas like crypto and advanced data services.

Outlook

CME’s recent trends point to a generally favorable outlook: a scalable, high‑margin business model; rising cash generation; and a strong competitive position anchored in essential market infrastructure. If the company continues to execute on its technology roadmap, expand its product set into emerging areas, and maintain disciplined capital management, it is well positioned to sustain attractive financial characteristics over time. The main uncertainties are external—regulatory shifts, market‑cycle impacts on trading activity, and competitive dynamics—and internal around the flawless execution of complex innovation projects. Overall, the business appears structurally strong, with its future trajectory largely dependent on how effectively it navigates these evolving risks and opportunities.